scispace - formally typeset
Open AccessJournal ArticleDOI

Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer.

Reads0
Chats0
TLDR
Immunohistochemical analysis of 303 clinical specimens from three independent cohorts of lung cancer patients and controls show that expression of ALDH1 is positively correlated with the stage and grade of lung tumors and related to a poor prognosis for the patients with early-stage lung cancer.
Abstract
Tumor contains small population of cancer stem cells (CSC) that are responsible for its maintenance and relapse. Analysis of these CSCs may lead to effective prognostic and therapeutic strategies for the treatment of cancer patients. We report here the identification of CSCs from human lung cancer cells using Aldefluor assay followed by fluorescence-activated cell sorting analysis. Isolated cancer cells with relatively high aldehyde dehydrogenase 1 (ALDH1) activity display in vitro features of CSCs, including capacities for proliferation, self-renewal, and differentiation, resistance to chemotherapy, and expressing CSC surface marker CD133. In vivo experiments show that the ALDH1-positive cells could generate tumors that recapitulate the heterogeneity of the parental cancer cells. Immunohistochemical analysis of 303 clinical specimens from three independent cohorts of lung cancer patients and controls show that expression of ALDH1 is positively correlated with the stage and grade of lung tumors and related to a poor prognosis for the patients with early-stage lung cancer. ALDH1 is therefore a lung tumor stem cell-associated marker. These findings offer an important new tool for the study of lung CSCs and provide a potential prognostic factor and therapeutic target for treatment of the patients with lung cancer. (Mol Cancer Res 2009;7(3):330–8)

read more

Citations
More filters
Book ChapterDOI

Overcoming Radioresistance of Lung Cancer Stem Cells

TL;DR: Therapeutic modifications that augment the effects of radiotherapy on CSCs are likely to improve outcomes for lung cancer patients.

Polo-like kinase 1 as a prognostic and therapeutic target in high-grade brain tumors

TL;DR: A meta-analysis of mouse models and cell of origin of Glioblastoma and MB shows clear trends in prognosis, disease progression, and treatment protocol followed by a review of current treatment protocols and recommendations for further studies are found.
Book ChapterDOI

Cancer Stem Cells in Lung Cancer: Distinct Differences between Small Cell and Non-Small Cell Lung Carcinomas

TL;DR: This work aims to provide a history of infectious disease in Yokohama from 1989 to 2002, a period chosen in order to explore its roots as well as specific cases up to and including the year of World War II.
Journal ArticleDOI

The Most Well - known Markers of CSCs and Their Role in Growth of Tumors, Drug Resistance and Metastasis

TL;DR: The capability of cancer cells including tumor initiation, maintenance, and extension is associated with cancer stem cells (CSCs), and the substantial features of CSCs are self- renewal and pluripotency.
Journal ArticleDOI

ALDH1A1 Gene Expression and Cellular Copper Levels between Low and Highly Metastatic Osteosarcoma Provide a Case for Novel Repurposing with Disulfiram and Copper

TL;DR: The findings support the feasibility of a repurposed drug strategy for Dis and Cu in combination with low-dose anthracycline to specifically target metastatic OS cells.
References
More filters
Journal ArticleDOI

Prospective identification of tumorigenic breast cancer cells

TL;DR: The ability to prospectively identify tumorigenic cancer cells will facilitate the elucidation of pathways that regulate their growth and survival and strategies designed to target this population may lead to more effective therapies.
Journal ArticleDOI

Stem cells, cancer, and cancer stem cells

TL;DR: Stem cell biology has come of age: Unequivocal proof that stem cells exist in the haematopoietic system has given way to the prospective isolation of several tissue-specific stem and progenitor cells, the initial delineation of their properties and expressed genetic programmes, and the beginnings of their utility in regenerative medicine.
Journal ArticleDOI

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

TL;DR: It is shown that normal and cancer human mammary epithelial cells with increased aldehyde dehydrogenase activity (ALDH) have stem/progenitor properties and these cells contain the subpopulation of normal breast epithelium with the broadest lineage differentiation potential and greatest growth capacity in a xenotransplant model.
Journal ArticleDOI

Tumour stem cells and drug resistance

TL;DR: Gaining a better insight into the mechanisms of stem-cell resistance to chemotherapy might lead to new therapeutic targets and better anticancer strategies.
Journal ArticleDOI

Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer

TL;DR: Although bronchiolar cells and alveolar cells are proposed to be the precursor cells of adenocarcinoma, this work points to bronchioalveolar stem cells as the putative cells of origin for this subtype of lung cancer.
Related Papers (5)